With a market cap of $455 billion, Johnson & Johnson (JNJ) is a global healthcare conglomerate headquartered in New Brunswick ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

President Trump’s executive order, which aimed to lower U.S. drug prices to align with international rates, initially triggered a negative market reaction for pharmaceutical stocks. However, these ...

The company’s Moderate operating performance and financial health, combined with its High valuation, make the stock appear ...

Johnson & Johnson has slashed on Wednesday its estimate for the impact of tariffs in 2025, which it now expects to be around $200 million. The company's stock (JNJ) is climbing in morning trading, ...

Health care giant Johnson & Johnson (NYSE:JNJ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter ...

Johnson & Johnson faces legal pressures from talc lawsuits, which are likely to create persisting growth and valuation headwinds. The latest dividend increase of 4.8% signals continued profit growth, ...